Lack of association between thrombophilic gene variants and recurrent pregnancy loss

References

• Altomare, I., Adler, A., & Aledort, L.M. (2007). The 5,10 metylenetetrahydrofolate reductase C677T mutation and risk of fetal loss: a case series and review the literature. Thrombosis Journal, 5, 17.
   PubMedGoogle Scholar
• American Society for Reproductive Medicine. (2008). Patient's fact sheet: pregnancy loss. (http://www.asrm.org/uploadedFiles/ASRM_Content/Resources/Patient_Resources/Fact_Sheets_and_Info_Booklets/recurrent_preg_loss.pdf). Accessed 9/7/13.
   Google Scholar
• American Society for Reproductive Medicine. (2012). Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertility and Sterility, 98, 1103–1111.
   PubMedGoogle Scholar
• Bertina, R.M., Koeleman, B.P.C., Koster, T., Rosendaal, F.R., Dirven, R.J., de Ronde, H., et al. (1994). Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64–67.
   PubMed Web of Science ®Google Scholar
• Biswas, A., Choudhry, P., Mittal, A., Meena, A., Ranjan, R., Choudhry, V.P., & Saxena, R. (2008). Recurrent abortions in Asian Indians: no role of factor V Leiden Hong Kong/Cambridge mutation and MTHFR polymorphism. Clinical and Applied Thrombosis/Hemostasis, 14, 102–104.
   PubMed Web of Science ®Google Scholar
• Bombell, S. & McGuire, W. (2008). Cytokine polymorphisms in women with recurrent pregnancy loss: meta-analysis. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 48, 147–154.
   PubMed Web of Science ®Google Scholar
• Cao, Y., Xu, J., Zhang, Z., Huang, X., Zhang, A., Wang, J., et al. (2013). Association study between methylenetetrahydrofolate reductase polymorphisms and unexplained recurrent pregnancy loss: a meta-analysis. Gene, 514, 105–111.
   PubMedGoogle Scholar
• Cardona, H., Cardona-Maya, W., Gómez, J.G., Castañeda, S., Gómez, J.M., Bedoya, G., et al. (2008). Relación entre los polimorfismos de la metilen-tetrahidrofolato-reductasa y los niveles de homocisteína en mujeres con pérdida gestacional recurrente: perspectiva desde la nutrigenética. Nutrición Hospitalaria, 23, 277–282.
   PubMedGoogle Scholar
• Carp, H.J. (2009). Aspirin in recurrent miscarriage: is there an indication?Israel Medical Association Journal, 11, 178–182.
   PubMedGoogle Scholar
• Dissanayake, V.H., Sirisena, N.D., Weerasekera, L.Y., Gammulla, C.G., Seneviratne, H.R., & Jayasekara, R.W. (2012). Candidate gene study of genetic thrombophilic polymorphisms in pre-eclampsia and recurrent pregnancy loss in Sinhalese women. Journal of Obstetrics and Gynaecology Research, 38, 1168–1176.
   PubMed Web of Science ®Google Scholar
• Dizon-Townson, D., Miller, C., Sibai, B., Spong, C.Y., Thom, E., Wendel, G. Jr., et al.; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. (2005). The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstetrics and Gynecology, 106, 517–524.
   PubMed Web of Science ®Google Scholar
• D’Uva, M., Di Micco, P., Strina, I., Ranieri, A., Alviggi, C., Mollo, A., et al. (2008). Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy. Biologics: Targets & Therapy, 2, 897–902.
   PubMedGoogle Scholar
• Finan, R.R., Al-Irhayim, Z., Mustafa, F.E., Al-Zaman, I., Mohammed, F.A., Al-Khateeb, G.M., et al. (2010). Tumor necrosis factor-alpha polymorphisms in women with idiopathic recurrent miscarriage. Journal of Reproductive Immunology, 84, 186–192.
   PubMed Web of Science ®Google Scholar
• Firouzabadi, R.D., Ghasemi, N., Rozbahani, M.A., & Tabibnejad, N. (2009). Association of p53 polymorphism with ICSI/IVF failure and recurrent pregnancy loss. Australian and New Zealand Journal of Obstetrics and Gynaecology, 49, 216–219.
   PubMedGoogle Scholar
• Ford, H.B. & Schust, D.J. (2009). Recurrent pregnancy loss: etiology, diagnosis, and therapy. Reviews in Obstetrics and Gynecology, 2, 76–83.
   PubMedGoogle Scholar
• Fraga, L.R., Paludo, F.J., Bos, A.J, Ferraro, J.L., Dias, F.S., & Alho, C.S. (2013). More severe clinical course of cardiovascular dysfunction in intensive care unit patients with the 894TT eNOS genotype. Genetics and Molecular Research, 12, 562–568.
   PubMedGoogle Scholar
• Fraga, L.R., Dutra, C.G., Boquett, J.A., Vianna, F.S.L., Gonçalves, R.O., Paskulin, D.D., et al. (2014). p53 signaling pathway polymorphisms associated to recurrent pregnancy loss. Molecular Biology Reports, 41, 1871–1877.
   PubMed Web of Science ®Google Scholar
• Kerkeni, M., Addad, F., Chauffert, M., Myara, A., Ben Farhat, M., Miled, A., et al. (2006). Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease. Clinical Chemistry, 52, 53–58.
   PubMed Web of Science ®Google Scholar
• Kovalevski, G., Gracia, C.R., Berlin, J.A., Sammel, M.D., & Barnhart, K.T. (2004). Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis. Archives of Internal Medicine, 164, 558–563.
   PubMedGoogle Scholar
• Krabbendam, I., Franx, A., Bots, M.L., Fijnheer, R., & Bruinse, H.W. (2005). Thrombophilias and recurrent pregnancy loss: a critical appraisal of the literature. European Journal Obstetrics, Gynecology and Reproductive Biology, 118, 143–153.
   PubMed Web of Science ®Google Scholar
• Kumar, S. (2011)Occupational, environmental and lifestyle factors associated with spontaneous abortion. Reproductive Sciences, 18, 915–930.
   PubMed Web of Science ®Google Scholar
• Lahiri, D.K. & Nurnberger, J.I. Jr. (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Research, 19, 5444.
   PubMed Web of Science ®Google Scholar
• Lissalde-Lavigne, G., Fabbro-Peray, P., Cochery-Nouvellon, E., Mercier, E., Ripart-Neveu, S., Balducchi, J.P., et al. (2005). Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control ‘NOHA first’ study. Journal of Thrombosis and Haemostasis, 3, 2178–2184.
   PubMed Web of Science ®Google Scholar
• Mahjoub, T., Mtiraoui, N., Tamim, H., Hizem, S., Finan, R.R., Nsiri, B., & Almawi, W.Y. (2005). Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages. American Journal of Hematology, 80, 12–19.
   PubMed Web of Science ®Google Scholar
• Marroni, A.S., Metzger, I.F., Souza-Costa, D.C., Nagassaki, S., Sandrim, V.C., Correa, R.X., et al. (2005). Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide: Biology and Chemistry, 12, 177–182.
   PubMed Web of Science ®Google Scholar
• Mayor-Olea, A., Callejón, G., Palomares, A.R., Jiménez, A.J., Gaitán M.J., Rodríguez, A., et al. (2008). Human genetic selection on the MTHFR 677C> T polymorphism. BMC Medical Genetics, 28, 104.
   Google Scholar
• Morales-Machín, A., Borjas-Fajardo, L., Quintero, J.M., Zabala, W., Alvarez, F., Delgado, W., et al. (2009). Polimorfismo C677T Del gen de la metiltetrahidrofolato reductase como factor de riesgo em mujeres com aborto recurrente. Investigación Clínica, 50, 327–333.
   PubMed Web of Science ®Google Scholar
• Miyamoto, Y., Saito, Y., Nakayama, M., Shimasaki, Y., Yoshimura, T., Yoshimura, M., et al. (2000). Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a 786T–> C mutation associated with coronary spastic angina. Human Molecular Genetics, 9, 2629–2335.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay, R., Saraswathy, K.N., & Ghosh, P.K. (2009). MTHFR C677T and factor V Leiden in recurrent pregnancy loss: a study among an endogamous group in North India. Genetic Testing and Molecular Biomarkers, 13, 861–865.
   PubMed Web of Science ®Google Scholar
• Pasquier, E., Bohec, C., Mottier, D., Jaffuel, S., Mercier, B., Férec, C., et al. (2009). Inherited thrombophilias and unexplained pregnancy loss: an incident case-control study. Journal of Thrombosis and Haemostasis, 7, 306–311.
   PubMed Web of Science ®Google Scholar
• Pihusch, R., Buchholz, T., Lohse, P., Rübsamen, H., Rogenhofer, N., Hasbargen, U., et al. (2001). Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester. American Journal of Reproductive Immunology, 46, 124–131.
   PubMed Web of Science ®Google Scholar
• Powers, R.W., Dunbar, M.S., Gallaher, M.J., & Roberts, J.M. (2003). The 677 C-T methylenetetrahydrofolate reductase mutation does not predict increased maternal homocysteine during pregnancy. Obstetrics and Gynecology, 101, 762–766.
   PubMed Web of Science ®Google Scholar
• Rai, R. & Regan, L. (2006). Recurrent miscarriage. Lancet, 368, 601–611.
   PubMed Web of Science ®Google Scholar
• Raffaelli, F., Nanetti, L., Vignini, A., Mazzanti, L., Giannubilo, S.R., Curzi, C.M., et al. (2010). Nitric oxide platelet production in spontaneous miscarriage in the first trimester. Fertility and Sterility, 93, 1976–1982.
   PubMed Web of Science ®Google Scholar
• Roqué, H., Paidas, M.J., Funai, E.F., Kuczynski, E., & Lockwood, C.J. (2004). Maternal thrombophilias are not associated with early pregnancy loss. Thrombosis and Haemostasis, 91, 290–295.
   PubMed Web of Science ®Google Scholar
• Rossmanith, W.G., Hoffmeister, U., Wolfahrt, S., Kleine, B., McLean, M., Jacobs, R.A., & Grossman, A.B. (1999). Expression and functional analysis of endothelial nitric oxide synthase (eNOS) in human placenta. Molecular Human Reproduction, 5, 487–494.
   PubMed Web of Science ®Google Scholar
• Sahin-Tóth, M., Kukor, Z., & Tóth, M. (1997). Tetrahydrobiopterin preferentially stimulates activity and promotes subunit aggregation of membrane-bound calcium-dependent nitric oxide synthase in human placenta. Molecular Human Reproduction, 3, 293–298.
   PubMedGoogle Scholar
• Sehirali, S., Inal, M.M., Yildirim, Y., Balim, Z., Kosova, B., Karamizrak, T., et al. (2005). Prothrombin G20210A mutation in cases with recurrent miscarriage: a study of the mediterranean population. Archives of Gynecology and Obstetrics, 273, 170–173.
   PubMedGoogle Scholar
• Serrano, F., Lima, M.L., Lopes, C., Almeida, J.P., & Branco, J. (2011). Factor V Leiden and prothrombin G20210A in Portuguese women with recurrent miscarriage: is it worthwhile to investigate?Archives of Gynecology and Obstetrics, 284, 1127–1132.
   PubMedGoogle Scholar
• Shin, S.J., Lee, H.H., Cha, S.H., Kin, J.H., Shim, S.H., Choi, D.H., & Kim, N.K. (2010). Endothelial nitric oxide synthase gene polymorphisms (− 786T> C, 4a4b, 894G> T) and haplotypes in Korean patients with recurrent spontaneous abortion. European Journal Obstetrics, Gynecology and Reproductive Biology, 152, 64–67.
   PubMed Web of Science ®Google Scholar
• Silver, R.M., Zhao, Y., Spong, C.Y., Sibai, B., Wendel, G. Jr., Wenstrom, K., et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units (NICHD MFMU) Network. (2010). Prothrombin gene G20210A mutation and obstetric complications. Obstetrics and Gynecology, 115, 14–20.
   PubMed Web of Science ®Google Scholar
• Su, M.T., Lin, S.H., & Chen, Y.C. (2011). Genetic association studies of angiogenesis- and vasoconstriction-related genes in women withrecurrent pregnancy loss: a systematic review and meta-analysis. Human Reproduction Update, 17, 803–812.
   PubMed Web of Science ®Google Scholar
• Tesauro M., Thompson W.C., Rogliani P., Qi L., Chaudhary P.P., & Moss J. (2000). Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proceedings of the National Academy of Sciences U. S. A., 97, 2832–2835.
   PubMed Web of Science ®Google Scholar
• Torabi, R., Zarei, S., Zeraati, H., Zarnani, A.H., Akhondi, M.M., Hadavi, R., et al. (2012). Combination of thrombophilic gene polymorphisms as a cause of increased the risk of recurrent pregnancy loss. Journal of Reproduction & Infertility, 13, 89–94.
   PubMedGoogle Scholar
• Traina, E., Daher, S., Moron, A.F., Sun, S.Y., Franchim, C.S., & Mattar, R. (2011). Polymorphisms in VEGF, progesterone receptor and IL-1 receptor genes in women with recurrent spontaneous abortion. Journal of Reproductive Immunology, 88, 53–57.
   PubMed Web of Science ®Google Scholar
• Vianna, F.S., Fraga, L.R., Tovo-Rodrigues, L., Tagliani-Ribeiro, A., Biondi, F., Maximino, C.M., et al. (2013). Polymorphisms in the endothelial nitric oxide synthase gene in thalidomide embryopathy. Nitric Oxide, 35, 89–92.
   PubMedGoogle Scholar
• Yenicesu, G.I., Cetin, M., Ozdemir, O., Cetin, A., Ozen, F., Yenicesu, C., et al. (2009). A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss. American Journal Reproductive Immunology, 63, 126–136.
   PubMedGoogle Scholar
• Zammiti, W., Mtiraoui, N., & Mahjoub, T. (2007). Lack of consistent association between endothelial nitric oxide synthase gene polymorphisms, homocysteine levels and recurrent pregnancy loss in Tunisian women. American Journal Reproductive Immunology, 59, 139–145.
   Google Scholar